Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

(2012) Teresa Diago et al.   MAYO CLINIC PROCEEDINGS

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

(2009) Thomas A Ciulla et al.   CURRENT OPINION IN OPHTHALMOLOGY

Cytoprotective effects of a blue light–filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-α, Bax, and Bcl-2 expression

(2009) Marcus Kernt et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

COMBINATION ANGIOSTATIC THERAPIES

(2009) GHOLAM A. PEYMAN et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

RATIONALE FOR COMBINATION THERAPY IN AGE-RELATED MACULAR DEGENERATION

(2009) RICHARD F. SPAIDE   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Role of platelet-derived growth factors in physiology and medicine

(2008) J. Andrae et al.   GENES & DEVELOPMENT

In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment

(2008) Marcus Kernt et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

Targeting Intraocular Neovascularization and Edema — One Drop at a Time

(2008) Lloyd Paul Aiello   NEW ENGLAND JOURNAL OF MEDICINE

Age-Related Macular Degeneration

(2008) Rama D. Jager et al.   NEW ENGLAND JOURNAL OF MEDICINE

Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib® treatment

(2007) Marcus Kernt et al.   ACTA OPHTHALMOLOGICA